DN Research / Sources you can keep
Published research files for analysts, journalists and builders. Link to the evidence behind a claim, preserve its date and carry its limitations into your work.
This directory covers the latest published Decision Brief snapshots, the Markets dataset, claim annotations, dated source follow-ups, comparison claim mappings and update mappings linked here. The underlying versioned files are fixed snapshots. Current research pages may evolve; cite the exact-version source when reproducibility matters.
Annotation and comparison-mapping dates describe publication; the update registry labels its latest linked publication separately. These dates do not refresh the original research. Review dates describe DN’s source review, not a provider release date. These files contain documentation research, not live prices, trading availability, independent audits or performance results. A newer publication does not automatically establish better or safer conditions.
The download is a JSON directory of links, versions, scope and citations. Follow each evidence JSON link to obtain the underlying file. No API key or account is needed to open these public snapshots.
25 of 25 assets shown.
ApeX Omni separates funding from trading balances and supports cross collateral. API signing controls and withdrawal liquidity conditions deserve separate checks from a trading-fee headline.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare funding paths, fee bases and exit conditions across three different perpetual systems. Gasless trading, signed fee caps and rewards are not interchangeable cost measures.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Aster orderbook perpetuals distinguish cross, isolated and multi-asset margin. Shared collateral, negative balances and withdrawal constraints can matter more than a headline trading rate.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Claim-level evidence types, publisher origins and conditions that would change conclusions across 14 platform briefs.
Annotation publication is not a new source review. Preserve each referenced snapshot’s original review date and limitations.
Links published follow-ups to specific claim IDs and brief versions, with their documented implications.
A mapping is not a new review or a live monitoring service. The latest mapped publication date does not establish the registry’s publication date.
Follow related platform claims from six dated comparisons, with unmapped evidence gaps preserved.
Related claims may support only part of a comparison row. Navigation mappings do not constitute independent verification or refresh the underlying source-review dates.
Crypto benchmarks, tokenised instrument structures, AI business exposure and institutional diligence questions.
Editorial documentation summaries, not live prices, performance data, execution observations or a licensed market feed.
EVEDEX documentation separates USDT settlement, notional-based trading costs and activity-linked rewards. A cashback balance or wallet connection does not establish net cost or withdrawal reliability.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Funding route, settlement chain and pool collateral are different decisions. This Arbitrum-focused GMX brief examines those boundaries, fee components, conditional exits and delegated trading permissions.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare direct markets, aggregated routes and a hybrid trading engine. Follow the actual liquidity source, collateral and exit steps before comparing costs.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
GRVT distinguishes single-asset and multi-asset margin. USDC collateral support does not change USDT settlement, and a shortfall can introduce borrowing costs.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Collateral depends on the deployment. USDC has not universally replaced DAI. Check the selected network, collateral and full cost breakdown before considering a position.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare the documented conditions, not an unsupported winner. Base is the shared deployment in this comparison; fee evidence is incomplete and no comparable live execution tests have been performed.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Collateral, shared margin and fee treatment depend on account mode and market. This brief separates unified accounts, portfolio margin and standard mode instead of treating every Hyperliquid balance alike.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare account modes, collateral recognition, fee conditions and evidence gaps. Zero commission and shared balances do not establish total cost, withdrawal reliability or a safest-platform winner.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Zero maker/taker fees apply to Standard accounts, while Plus and Premium use different terms. Margin mode is a separate choice, and non-USDC collateral introduces haircuts and liquidation exposure.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
MUX is a suite, not one uniform execution venue. Aggregator routes can combine underlying protocols, while native V3 pools and leverage boosting introduce distinct collateral and cost conditions.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
MYX V2 ties execution and fees to market conditions. Its documentation also describes rolling profit locks that can restrict withdrawals and use of profits in other markets.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare MYX V2 profit portability with Aster margin and transfer constraints. Fee labels, realised profits and promotional credits need separate checks.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Paradex classifies orders as Retail or Pro by submission method. That affects fees and execution conditions, while the reviewed collateral guide requires USDC for perpetual trading.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare order classification, usable collateral and settlement obligations. A USDC balance can have very different consequences for margin, debt and withdrawals.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
SAI documents gasless trading on Nibiru, but trading, trigger and rapid-close charges remain separate. Collateral and holding-time conditions are essential to any cost comparison.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
SynFutures combines onchain orderbook and AMM liquidity for perpetuals. The reviewed tutorial distinguishes available balance, position margin and liquidity positions that can become trading exposure.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Avantis now identifies as Veranta. Its current material describes USDC margin on Base and distinct fee models for RWA trading and Upside Perps. Neither a rebrand nor a zero-commission headline establishes total cost, safety or eligibility.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Access gaps resolved for these four retrieved pages; fee inconsistencies and live validation remain unresolved.
No live trading, collateral, permission or payout tests. No user-specific eligibility assessment. Other sources in the original snapshot were not reverified by this follow-up. A content hash identifies the retrieved text, not its truth, authenticity or future availability.
